<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02204865</url>
  </required_header>
  <id_info>
    <org_study_id>14/LO/0077</org_study_id>
    <nct_id>NCT02204865</nct_id>
  </id_info>
  <brief_title>Validation of the ApneaScan Algorithm in Sleep Disordered Breathing</brief_title>
  <acronym>ApneaScan</acronym>
  <official_title>Sleep-Disordered Breathing in Patients With Implanted Cardiac Devices: Validation of the ApneaScan Algorithm and Implications for Prognosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Brompton &amp; Harefield NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Royal Brompton &amp; Harefield NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep disordered breathing, in which patients my breath deeply, shallowly or stop breathing
      for periods whilst asleep, is common in heart failure and associated with a poor prognosis.
      This study aims to validate a novel function available on certain pacemakers which is
      designed to detect this condition.The investigators hypothesize that ApneaScan can accurately
      detect moderate to severe sleep disordered breathing in patients with heart failure as
      compared against an Embletta sleep study. The investigators will also follow up our patients
      for 2 years to determine whether the severity of sleep disordered breathing as assessed by
      ApneaScan correlates with prognosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      72 patients with heart failure with reduced ejection fraction (HFREF) who have been selected
      to receive an Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronization
      Therapy Pacemaker or Defibrillator (CRT-P/D) will undergo pre-implant assessment with an
      echocardiogram, B-type Natriuretic Peptide (BNP) level, 6 minute walk test, Minnesota living
      with heart failure and Epworth sleepiness questionnaires. The patients will then have the
      device implanted. 6 to 8 weeks later the patent will undergo an Embletta home sleep study and
      download of the ApneaScan data from the device. The mean Apnoea-Hypopnoea Index (AHI) from
      the ApneaScan download will be compared with that derived from the sleep study. The patients
      will also have a repeat 6 minute walk test, echocardiogram and BNP level.

      2 years after device implantation, all patients will be followed up to document deaths,
      hospital admissions, Atrial Fibrillation (AF) burden and appropriate therapies from ICD
      devices.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Apnoeic-Hypopnoeic Index (AHI)</measure>
    <time_frame>18 months</time_frame>
    <description>We will compare that AHI from the ApneaScan pacemaker algorithm against the AHI from an Embletta sleep study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse heart failure events</measure>
    <time_frame>2 years</time_frame>
    <description>Comprising hospital admissions for heart failure, AF burden, VF and VT burden and mortality</description>
  </secondary_outcome>
  <other_outcome>
    <measure>B-Type Natriuretic peptide (BNP) concentration</measure>
    <time_frame>2 years</time_frame>
    <description>BNP concentration correlated with severity of SDB</description>
  </other_outcome>
  <other_outcome>
    <measure>Ejection fraction on echocardiography</measure>
    <time_frame>2 years</time_frame>
    <description>Correlation of ejection fraction and severity of SDB</description>
  </other_outcome>
  <other_outcome>
    <measure>6 minute walk test distance</measure>
    <time_frame>2 years</time_frame>
    <description>Correlation between 6MWTd and severity of SDB</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Sleep-Disordered Breathing</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Pacemaker/ICD with ApneaScan</arm_group_label>
    <description>Patients with HFREF due to receive a pacemaker or ICD with ApneaScan function</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker/ICD</intervention_name>
    <description>Implantation of an ICD or CRT device with ApneaScan function</description>
    <arm_group_label>Pacemaker/ICD with ApneaScan</arm_group_label>
    <other_name>Invive, Inliven, Incepta, Energen, Autogen devices.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with heart failure with reduced ejection fraction (EF &lt;40%) due to receive a
        Boston Scientific ICD/CRTD/P with ApneaScan function.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heart failure with reduced ejection fraction (EF &lt; 40%)

          -  Due to receive a device with ApneaScan function

          -  Able to give informed consent

          -  Ambulatory

        Exclusion Criteria:

          -  Known sleep disordered breathing on Non-Invasive Ventilation therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Vazir, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Brompton &amp; Harefield NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simon G Pearse, MBChB</last_name>
    <phone>02073528121</phone>
    <phone_ext>2003</phone_ext>
    <email>s.pearse@rbht.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ali Vazir, MBBS</last_name>
    <phone>02073528121</phone>
    <phone_ext>7716</phone_ext>
    <email>a.vazir@imperial.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Brompton and Harefield NHS Trust</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon G Pearse, MBChB</last_name>
      <phone>02073528121</phone>
      <phone_ext>2003</phone_ext>
      <email>s.pearse@rbht.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Ali Vazir, PhD</last_name>
      <phone>02073528121</phone>
      <phone_ext>2060</phone_ext>
      <email>a.vazir@imperial.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Simon G Pearse, MBChB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ali Vazir, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Cowie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Polkey, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rakesh Sharma, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tom Wong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2014</study_first_submitted>
  <study_first_submitted_qc>July 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2014</study_first_posted>
  <last_update_submitted>November 8, 2016</last_update_submitted>
  <last_update_submitted_qc>November 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep-Disordered Breathing</keyword>
  <keyword>Sleep Apnoea</keyword>
  <keyword>Heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

